Description
Tirzepatide activates both GIP and GLP-1 receptors. It is a 39-residue peptide with a C20 fatty diacid side chain that supports once-weekly pharmacokinetics, and metabolic research studies it for blood-sugar control, appetite regulation and body-weight reduction.
Supplied by LiliPeptide in boxes of 10 vials, priced per box. The strength shown is the amount in each vial.
For research use only. Not for human or veterinary use.





